Use of Catarantus roseus in the treatment of oncological diseases

Abstract

Regardless of the stage and form of the oncological disease, phytotherapy has a sufficient arsenal of drugs that can adequately supplement the etiopathogenetic, syndromic and symptomatic treatment of patients, which increases the quality of their life and prolongs it. One such remedy is Cathartthus roseus, a perennial evergreen half-shrub that belongs to a small genus of herbaceous plants of the genus Cathartthus. Cathartthus roseus contains more than 80 different indole alkaloids. The healing properties of Cathartthus roseus are caused, first of all, by the presence in the plant of plant-derived cytostatics vinblastine and vincristine. Medicines based on Catharitus roseus are most effective in the treatment of lymphomas, Kaposi's sarcoma, Letterter-Siva disease, chorionic carcinoma resistant to other chemotherapeutic drugs, neuroblastoma resistant to hormone therapy, inoperable breast cancer, severe forms of fungal mycosis, myeloma disease, germicogenic testicular and ovarian tumors, cancer of kidney, bladder, nasopharynx, lung.